This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Streptococcus suis is a zoonotic pathogen; survivors of invasive infection may have persistent auditory or vestibular sequelae. To address limited multicenter evidence from China, we characterized 90-day outcomes, antimicrobial susceptibility, and exploratory genomic findings. METHODS: We retrospectively studied 34 patients with invasive S. suis infection at eight hospitals in four Chinese provinces (2017-2025). Unfavorable outcome was defined as death within 90 days or persistent sequelae at day 90. Minimum inhibitory concentrations were reinterpreted using Clinical and Laboratory Standards Institute viridans-group streptococcal surrogate breakpoints; six recoverable isolates underwent whole-genome sequencing. RESULTS: Acute cochleovestibular involvement occurred in 11/27 (40.7%) patients with meningitis and 0/7 with nonmeningitic bacteremia/sepsis. Unfavorable outcomes occurred in 17/34 (50.0%) patients, including two deaths; 12/32 (37.5%) survivors had hearing-related sequelae. Acute cochleovestibular involvement was more frequent among patients with unfavorable outcomes (64.7% vs 0%; P < 0.001). All evaluable isolates were susceptible to penicillin (21/21), cefotaxime (19/19), and ceftriaxone (5/5). Resistance was observed in 17/20, 16/20, and 20/20 isolates tested for erythromycin, clindamycin, and tetracycline, respectively. Sequence types were ST1 (n = 3), ST7 (n = 2), and ST25 (n = 1); epf and sly were each detected in five isolates, and mrp in four. CONCLUSION: Substantial hearing-related morbidity supports structured audiological follow-up. Clinical associations and genomic findings remain exploratory and do not establish independent prognostic value or genotype-phenotype causality.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: